Pfizer Inc
Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say
A health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United States, on Dec. 17, 2022. Xinhua News Agency | Getty Images People who receive Pfizer‘s RSV vaccine for older adults should be monitored for Guillain-Barre syndrome, after two people developed the nervous system disorder after […]
Read More
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
A Johnson & Johnson building is shown in Irvine, California. Mike Blake | Reuters Johnson & Johnson on Wednesday said it’s ducking out of the RSV vaccine race, weeks after competitors Pfizer and GSK inched closer to launching the world’s first shot against the deadly virus. J&J will stop working on its investigational RSV adult […]
Read More
BioNTech shares slip on gloomy Covid vaccine sales outlook
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Shares of BioNTech on Monday slid by more than 6% in morning trading after the German drugmaker shared a gloomy 2023 sales outlook for its […]
Read More
Pfizer signals settlement with China on improving upon health coverage in the place
Pfizer CEO Albert Bourla speaks all through the China Improvement Forum in Beijing on March 25, 2023. Lintao Zhang | Getty Photographs Information | Getty Illustrations or photos BEIJING — U.S. pharma big Pfizer has signed an settlement with China to cooperate on strengthening the country’s health coverage, according to the business. “We are aligned […]
Read More
Pfizer’s Covid drug Paxlovid may reduce the risk of developing long Covid, study says
A prescription for Pfizers Paxlovid tablets outside of his apartment in Philadelphia, Pennsylvania on April 25, 2022. (Photo by Rachel Wisniewski/For the Washington Post) Rachel Wisniewski | The Washington Post | Getty Images People who take Pfizer‘s Covid antiviral treatment Paxlovid shortly after infection may reduce their risk of developing long Covid, regardless of their […]
Read More
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. Jennifer Lorenzini | Reuters The Food and Drug Administration’s independent panel of advisors recommended full approval of Pfizer’s Covid-19 antiviral pill Paxlovid for high-risk adults 16-1 on Thursday, but flagged potentially harmful drug interactions. The treatment […]
Read More
Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
President Joe Biden delivers remarks about the Build Back Better legislation’s new rules around prescription drug prices in the East Room of the White House on December 06, 2021 in Washington, DC. Chip Somodevilla | Getty Images Five of Pfizer’s drugs will cost less for Medicare recipients starting next month as part of President Joe […]
Read More
FDA authorizes Pfizer’s Covid omicron booster as fourth shot for kids under 5
A staff member draws up a syringe with the Comirnaty vaccine from Biontech and Pfizer adapted to the Omicron-BA.1 variant at the Mainz vaccination center. Sebastian Christoph Gollnow | dpa | Picture Alliance | Getty Images The U.S. Food and Drug Administration on Tuesday authorized Pfizer’s omicron booster shot for kids under five years old […]
Read More
FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults
In this photo illustration, Pfizer’s Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida. Joe Raedle | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support the drug’s use in adults at high risk of progressing to severe disease. The […]
Read More
CNBC Day-to-day Open up: Banking institutions acquired hammered by SVB’s collapse. But the Fed could possibly continue to elevate premiums
The exterior of a First Republic Financial institution branch is seen on Barclay Street on March 13, 2023 in New York Metropolis. Michael M. Santiago | Getty Visuals Information | Getty Photographs This report is from present-day CNBC Every day Open, our new, global markets e-newsletter. CNBC Everyday Open delivers traders up to pace on […]
Read More